English
Français
Deutsch
Italiano
Português
Русский
Español
简体中文
हिन्दी
日本語
By Josh Beckerman
Enfusion shares were recently up 20% to $11.05 after Reuters reported the software company has received takeover interest from Francisco Partners, Vista Equity Partners and Irenic Capital Management in recent months.
Volume was 1.98 million shares, compared with a 65-day average of 407,890.
The report cited several people familiar with the matter. Enfusion didn’t immediately respond to request for comment from Dow Jones Newswires.
FTV Capital, which invested in Enfusion in 2016, bought 1.14 million shares on June 15 and entered a 180-day lockup agreement, according to securities filings.
Write to Josh Beckerman at [email protected]
Read the full article here